Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$3.17 - $7.91 $131,532 - $328,209
41,493 Added 757.59%
46,970 $160,000
Q2 2023

Jul 28, 2023

SELL
$7.35 - $13.21 $20,116 - $36,155
-2,737 Reduced 33.32%
5,477 $40,000
Q1 2023

May 15, 2023

SELL
$7.79 - $16.29 $225 - $472
-29 Reduced 0.35%
8,214 $85,000
Q4 2022

Feb 07, 2023

SELL
$11.0 - $21.45 $18,403 - $35,885
-1,673 Reduced 16.87%
8,243 $97,000
Q3 2022

Nov 14, 2022

SELL
$20.09 - $35.8 $52,234 - $93,079
-2,600 Reduced 20.77%
9,916 $208,000
Q2 2022

Aug 09, 2022

BUY
$27.42 - $43.63 $575 - $916
21 Added 0.17%
12,516 $388,000
Q1 2022

May 04, 2022

SELL
$36.48 - $52.22 $67,415 - $96,502
-1,848 Reduced 12.88%
12,495 $513,000
Q4 2021

Feb 09, 2022

BUY
$33.11 - $55.01 $2,218 - $3,685
67 Added 0.47%
14,343 $623,000
Q3 2021

Nov 04, 2021

SELL
$50.07 - $66.05 $30,542 - $40,290
-610 Reduced 4.1%
14,276 $715,000
Q2 2021

Aug 12, 2021

BUY
$56.61 - $80.46 $181,208 - $257,552
3,201 Added 27.39%
14,886 $938,000
Q1 2021

May 10, 2021

SELL
$86.23 - $125.19 $6,036 - $8,763
-70 Reduced 0.6%
11,685 $1.09 Million
Q2 2020

Aug 10, 2020

SELL
$54.33 - $89.52 $8,203 - $13,517
-151 Reduced 1.27%
11,755 $930,000
Q1 2020

May 11, 2020

SELL
$49.34 - $68.76 $8,930 - $12,445
-181 Reduced 1.5%
11,906 $689,000
Q4 2019

Feb 13, 2020

SELL
$51.21 - $59.06 $14,594 - $16,832
-285 Reduced 2.3%
12,087 $652,000
Q3 2019

Nov 12, 2019

SELL
$40.6 - $57.2 $4,344 - $6,120
-107 Reduced 0.86%
12,372 $647,000
Q2 2019

Aug 12, 2019

SELL
$39.92 - $53.86 $11,417 - $15,403
-286 Reduced 2.24%
12,479 $603,000
Q4 2018

Feb 13, 2019

SELL
$55.63 - $73.24 $61,193 - $80,564
-1,100 Reduced 7.93%
12,765 $757,000
Q2 2018

Aug 10, 2018

SELL
$48.33 - $55.64 $35,909 - $41,340
-743 Reduced 5.09%
13,865 $700,000
Q4 2017

Feb 09, 2018

SELL
$37.77 - $47.75 $137,445 - $173,762
-3,639 Reduced 19.94%
14,608 $679,000
Q3 2017

Oct 20, 2017

BUY
$34.14 - $40.45 $622,952 - $738,091
18,247
18,247 $738,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.